Agios Pharmaceuticals (AGIO) Equity Ratio: 2012-2025
Historic Equity Ratio for Agios Pharmaceuticals (AGIO) over the last 13 years, with Sep 2025 value amounting to 0.93.
- Agios Pharmaceuticals' Equity Ratio rose 2.09% to 0.93 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.93, marking a year-over-year increase of 2.09%. This contributed to the annual value of 0.93 for FY2024, which is 7.06% up from last year.
- Per Agios Pharmaceuticals' latest filing, its Equity Ratio stood at 0.93 for Q3 2025, which was down 0.43% from 0.93 recorded in Q2 2025.
- Over the past 5 years, Agios Pharmaceuticals' Equity Ratio peaked at 0.94 during Q1 2025, and registered a low of 0.85 during Q2 2024.
- Over the past 3 years, Agios Pharmaceuticals' median Equity Ratio value was 0.90 (recorded in 2023), while the average stood at 0.90.
- In the last 5 years, Agios Pharmaceuticals' Equity Ratio soared by 91.86% in 2021 and then dropped by 3.84% in 2024.
- Quarterly analysis of 5 years shows Agios Pharmaceuticals' Equity Ratio stood at 0.90 in 2021, then decreased by 1.11% to 0.89 in 2022, then declined by 2.61% to 0.87 in 2023, then grew by 7.06% to 0.93 in 2024, then grew by 2.09% to 0.93 in 2025.
- Its last three reported values are 0.93 in Q3 2025, 0.93 for Q2 2025, and 0.94 during Q1 2025.